Medicare Enrolled
Dr. Don Enty, M.D.
Pain Medicine · Colleyville, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Enty from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Enty?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Enty
Dr. Don Enty is a pain medicine specialist in Colleyville, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Enty performed 4,848 Medicare services across 1,928 unique beneficiaries.
Between the years covered by Open Payments, Dr. Enty received a total of $2,722 from 29 pharmaceutical and/or device companies across 124 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Enty is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 13% volume in TX
$2,722 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,848
Medicare services
Top 13% in TX for pain medicine
1,928
Unique beneficiaries
$104
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~242 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,356 | $61 | $219 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
930 | $93 | $260 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
603 | $1 | $6 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
599 | $60 | $194 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
584 | $241 | $741 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
93 | $121 | $525 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
67 | $288 | $1,750 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
45 | $40 | $92 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
42 | $294 | $1,631 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
42 | $27 | $130 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
41 | $518 | $3,000 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
36 | $93 | $251 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
36 | $70 | $364 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
34 | $21 | $145 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
32 | $110 | $719 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
31 | $236 | $1,285 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
31 | $64 | $360 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
31 | $207 | $1,230 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
29 | $80 | $367 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
28 | $81 | $438 |
| Spinal neurostimulator electrode insertion A procedure to place an electrode array into the spine through the skin. The electrode is used to deliver electrical stimulation to the nervous system. |
28 | $1,350 | $7,500 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
28 | $106 | $567 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
25 | $195 | $596 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
20 | $492 | $2,850 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
17 | $51 | $202 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
15 | $88 | $388 |
| Electronic analysis of implanted neurostimulator with complex programming This procedure involves the electronic evaluation of an implanted neurostimulator generator. It includes complex programming of spinal cord or peripheral nerve stimulators. |
13 | $44 | $202 |
| Spinal neurostimulator generator insertion Surgical placement of a spinal neurostimulator generator or receiver device. |
12 | $153 | $1,500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$2,722
Total received (2018-2024)
Avg $389/year across 7 years
Bottom 47% in TX for pain medicine
29
Companies
124
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,722 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$386
2023
$353
2022
$154
2021
$810
2020
$240
2019
$364
2018
$415
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$936
Boston Scientific Corporation
$369
BOSTON SCIENTIFIC CORPORATION
$246
Teva Pharmaceuticals USA, Inc.
$215
Vertos Medical, Inc.
$134
Medtronic, Inc.
$134
Spinal Simplicity, LLC
$74
SI-BONE, INC.
$61
Nevro Corp.
$57
Medtronic USA, Inc.
$53
Nalu Medical, Inc.
$43
ABBVIE INC.
$40
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$37
Relievant Medsystems, Inc.
$35
Collegium Pharmaceutical, Inc.
$34
MML US, Inc.
$24
Nuvectra Corporation
$24
VERTEX PHARMACEUTICALS INCORPORATED
$23
SPR Therapeutics, Inc
$22
Vertiflex, Inc.
$22
Pernix Therapeutics Holdings, Inc.
$18
Horizon Therapeutics plc
$18
Sentynl Therapeutics, Inc.
$17
Horizon Pharma plc
$16
AstraZeneca Pharmaceuticals LP
$16
PFIZER INC.
$16
ASSERTIO THERAPEUTICS, Inc.
$15
PROTEGA PHARMACEUTIALS INC
$15
Stimwave Technologies Incorporated
$12
Top 3 companies account for 57.0% of total payments
Associated products mentioned in payments ›
AJOVY · Algovita · BOTOX · Gralise · HA MINUTEMAN G3-R · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · LYRICA · Levorphanol · MOVANTIK · NA · NT1100 NT2000iX Simplicity · Nalu Neurostimulation System · PENNSAID · PROCLAIM · Proclaim DRG IPG · Proclaim Family of SCS IPGs · Proclaim IPG · Protege Family of SCS IPGs · RELISTOR · ROXYBOND · ReActiv8 · SPECTRA WAVEWRITER · SPRINT PNS System · SUPERION · Senza Spinal Cord Stimulation System · StimQ Peripheral Nerve StimulatorSystem · Superion · Superion ISS · UBRELVY · WaveWriter Alpha Prime 16 · XTAMPZA · ZOHYDRO ER · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $56 per 100 Medicare services performed
Geographic Context
Pain medicines within 10 mi
88
Per 100K population
4.1
County median income
$81,905
Nearest hospital
SAINT CAMILLUS MEDICAL CENTER
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Enty is a clinical cardiology specialist, with above-average Medicare volume (top 13% in TX), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Enty experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Enty performed 1,356 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Enty receive payments from pharmaceutical companies?
Yes. Dr. Enty received a total of $2,722 from 29 companies across 124 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Enty's costs compare to other pain medicines in Colleyville?
Dr. Enty's average Medicare payment per service is $104. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Enty) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Colleyville
Browse pain medicines in Colleyville ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in TX
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in TX
Which TX pain medicines receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology